Treating Addiction in Chronic Pain Patients A Clinical Journey. Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest



Similar documents
Michigan Guidelines for the Use of Controlled Substances for the Treatment of Pain

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Kaiser Permanente Department of Addiction Medicine Panel May 21, 2010

Prescription Medication Abuse: Skills for Prevention and Intervention

Michigan Board of Nursing Guidelines for the Use of Controlled Substances for the Treatment of Pain

HAWAII BOARD OF MEDICAL EXAMINERS PAIN MANAGEMENT GUIDELINES

ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15

MANAGEMENT OF CHRONIC NON MALIGNANT PAIN

Pain, Addiction & Methadone

Naltrexone and Alcoholism Treatment Test

These changes are prominent in individuals with severe disorders, but also occur at the mild or moderate level.

Substance Abuse Issues in Pain Management

Opioid Contracts: A Tool for Providing Relief and Preventing Abuse?

Guidelines for Use of Controlled Substances for the Treatment of Pain

MQAC Rules for the Management of Chronic Non-Cancer Pain

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

Frequently asked questions

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

Opioid Treatment Agreement

Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling

Patients are still addicted Buprenorphine is simply a substitute for heroin or

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Managing Chronic Pain in Adults with Substance Use Disorders

The Chemical Coper Steven D. Passik, PhD

MSD Guidelines for the Use of Controlled Substances for the Treatment of Pain

CNCP and Addiction. Disclosures 17/02/2015. CPSNS CPSNL Atlantic Mentorship Network P&A. John Fraser February 18, 2015

DSM V criteria. Defining Opioid Use Disorder (Addiction)

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

CONTROLLED SUBSTANCE CONTRACT

Triage, Assessment & Treatment

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

Care Management Council submission date: August Contact Information

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Appendices to Interim Report on the Baltimore Buprenorphine Initiative. Managed Care Organization Information Pages

Disclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program The West Virginia Model

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

Addiction Medicine for FP / GP. Dr. Francisco Ward, DABPMR/PM SetonPainRehab.com setonpr@gmail.com

Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment

opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top

Today s Topics. Session 2: Introduction to Drug Treatment. Treatment matching. Guidelines: where should a client go for treatment?

Karla Ramirez, LCSW Director, Outpatient Services Laurel Ridge Treatment Center

American Society of Addiction Medicine

If the only tool you have is a hammer, you tend to see every problem as a nail.

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

ANCILLARY STABILIZATION AND WITHDRAWAL. The Why And How Of Stabilizing The Patient In A Comprehensive Treatment Setting

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

Behavioral Health Medical Necessity Criteria

Judith Martin, MD Medical Director, Substance Abuse Services, San Francisco DPH

Nurse Practitioner Controlled Substances Post Survey Analysis. May, 2013

Background & Significance

Treatment of Chronic Pain: Our Approach

Treatment Approaches for Drug Addiction

Sample Patient Agreement Forms

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Opioid Treatment Services, Office-Based Opioid Treatment

Alcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

Identifying and Managing Substance Use During Pregnancy

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

Doc Dial-in Discussion Series

Aberrant Drug-taking Behaviors: What Do We Know?

MEDICAL ASSISTANCE BULLETIN

Why Do I Need to Stay Abstinent

Update and Review of Medication Assisted Treatments

Drug Abuse and Addiction

OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use

Treatment Approaches for Drug Addiction

DrugFacts: Treatment Approaches for Drug Addiction

Table of Contents. I. Introduction II. Summary A. Total Drug Intoxication Deaths B. Opioid-Related Deaths... 9

TREATMENT MODALITIES. May, 2013

Methamphetamine. Like heroin, meth is a drug that is illegal in some areas of the world. Meth is a highly addictive drug.

Opioid/Opiate Dependent Pregnant Women

Prescription Drug Abuse

MOVING TOWARD EVIDENCE-BASED PRACTICE FOR ADDICTION TREATMENT

EPIDEMIC 4.6 % OF INDIVIDUALS USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.

How To Use Naltrexone Safely And Effectively

MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model

H-SOAP STUDY. Hospital-based Services for Opioid- and Alcohol-addicted Patients

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

Martha Brewer, MS, LPC,LADC. Substance Abuse and Treatment

Dependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania

Benzodiazepine Detoxification and Reduction of Long term Use

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

Produced and Published by The Cabin Chiang Mai, Alcohol and Drug Rehab Centre. Copyright and How is it Treated?

P3 / PERSONAL ASPECTS. Drugs

THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES

Substance Use Disorder Overview. Presented By Ecole J. Barrow-Brooks M.Ed & Darlene D. Owens MBA, LBSW, CADC, ADS

Triage, Assessment & Treatment Methadone 101/Hospitalist Workshop

Opiate Abuse and Mental Illness

Pain Management Regulations Affect More Than Pain Management Specialists January Of counsel to

Information for Pharmacists

What is Addiction? DSM-IV-TR Substance Abuse Criteria

MEDICAL ASSISTANCE BULLETIN

Adjunctive psychosocial intervention. Conditions requiring dose reduction. Immediate, peak plasma concentration is reached within 1 hour.

Opioid Agreement for Center for Pain Management S.C.

OUTPATIENT SUBSTANCE USE DISORDER SERVICES FEE-FOR-SERVICE

Substance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates

Primary Care Behavioral Interventions for Pain and Prescription Opioid Misuse

Impact of Systematic Review on Health Services: The US Experience

Transcription:

Treating Addiction in Chronic Pain Patients A Clinical Journey Brad Anderson, MD Chief, Department of Addiction Medicine Kaiser Permanente Northwest

Pain Addiction

Kaiser Permanente Northwest 480,000 members 1000+ clinicians Portland Metro and Salem in Oregon Vancouver and Longview in Washington

Department of Addiction Medicine 40 counselors 5 medical staff 11 medical offices 6,000 patients per year Level I, II, III, adult & adolescent Inpatient and outpatient detox Codependency treatment Chronic Pain Addiction Group (CPAG)

Diagnoses at Intake 70 60 50 40 30 20 10 Alcohol Amphetamine Cannabis No diagnosis Cocaine Opioid 0 1997 2000 2004

Half of referrals to Addiction Medicine from primary and specialty care are due to concerns about opioid addiction. Is this addiction? If so, what do I do about it?

Contract for long-term opioid therapy for chronic nonmalignant pain Single prescriber Medicine, dose, refills Risk / benefit Reasons to discontinue

Contract for long-term opioid therapy for chronic nonmalignant pain Introduced the concept that addiction is not an absolute contraindication to prescribing opioids Challenged the idea that opioid therapy is only for end-of-life care Developed with cooperation of state BMEs

Evaluation for appropriateness of long-term opioid therapy from an addiction medicine standpoint What we found Concerning behaviors were often due to inadequately treated pain, not addiction Rarely resulted in recommendation to discontinue opioids Physical dependence and addiction often confused

Evaluation for appropriateness of long-term opioid therapy from an addiction medicine standpoint What we found Mainly short acting opioids being prescribed Poor utilization of non-opioid therapies Difficult to make addiction diagnosis Patients with addiction who were on opioids for pain didn t fit well into standard treatment

Cougalgia Chronic pain syndrome seen in Washington State Cougar fans Also known as Pullman-ary hypertension Associated with Depression Anxiety PTSD Delusional thinking

Cougalgia Predominantly genetic with some environmental influence Differential diagnosis Cubosis Mal-de-Mariner Beavertigo Overlap with addiction Continued viewing despite adverse consequences Loss of remote control Compulsive ESPN use

Cougalgia - Treatments Three 10 win seasons with top 10 rating Unanticipated side effects 3 Apple Cup losses Dobamine Seahawk substitution therapy Rose Bowl victory probably only hope

Chronic Pain / Addiction Group I Initially lead by staff from both the Dept of Addiction Medicine and Pain Clinic Pain management strategies predominated during group time Eventually discontinued as census decreased

Chronic Pain / Addiction Group II Lead by counselor and physician assistant from the Dept of Addiction Medicine For inclusion, patients must have, and agree with, the diagnoses of Addiction Chronic pain Most patients were on an opioid and had addiction treatment experience All patients had an assessment and treatment plan

Chronic Pain / Addiction Group II Goal of the group To learn how to live with pain and addiction on a daily basis.

Chronic Pain / Addiction Group II In other words Learn how to have to opioids be a medication for pain without being a drug of choice Keeping things black and white

Pain Addiction

Chronic Pain / Addiction Group II In other words Learn how to have to opioids be a medication for pain without being a drug of choice Keeping things black and white Stay on the analgesic curve

DOSE 100 90 80 70 60 50 40 30 20 10 0 Analgesia Euphoria Pseudoaddiction Euphoria to Analgesia TIME

Name Your Treatment Column A Column B Column C New Step Program Change Direction House Life Point Group Turning Works Community Recovery Pathways System Health Day People Care Dawn Place Safe Roads Home Fresh Start Center

CPAG II Check In Name Substance of choice Sobriety date Number of meetings attended in past week Pain level Taking meds as prescribed? One word feeling today Do you need time in group today?

Chronic Pain / Addiction Group II To accomplish goals, coordination with the Primary Care Provider is key. Develop Opiate Therapy Plan Long acting opioids, scheduled, not PRN Eliminate short acting opioids Avoid benzodiazepines Random urine toxicology Referral to Pain Clinic and participation in pain management 8 week class

CPAG II 80 70 60 Female 76% 50 40 30 20 10 Male 24% 0

CPAG II Addiction Diagnoses 70 60 50 Opioid 69% 40 30 Alcohol 41% 20 10 0 Marijuana 16% Amphetamine 10% Other 10%

CPAG II Pain Diagnoses 60 50 Back/neck 60% 40 30 20 10 0 Fibromyalgia 28% Headaches 17% Arthritis 8% Other 12%

CPAG II Psych Diagnoses 80 70 60 Depression 72% 50 40 30 20 10 0 Anxiety 28% PTSD 20% Axis II 10% Other 16%

CPAG II Long Acting Opioids 60 50 40 Methadone 54% 30 20 Sustained release morpine 37% 10 0 Oxycontin 6%

Chronic Pain / Addiction Group II What we found Most patients love the group Need to remind patients that this is an addiction group, not a pain group Need to remind patients to attend a pain group Strong interplay between psychological factors (stress, anxiety), pain and addiction Patients who left the group and relapsed, often returned

Chronic Pain / Addiction Group II What we found The group DID NOT significantly change the behavior of the patients Primary Care Provider! 1. Opiate therapy plans not consistently developed 2. Short acting opiates were prescribed again 3. Urine toxicology not done

Research Opportunities Identify barriers to PCP cooperation with Addiction Medicine recommendations Development of meaningful and measurable outcome measures to assess efficacy of chronic pain / addiction groups Identify patient characteristics which would predict good or poor outcomes with opioid therapy Evaluate use of case managers to improve functioning and decrease health care utilization

For more information, please contact us Lucile Gauger, PA-C lucile.v.gauger@kp.org Christine Finucane, LCSW christine.f.finucane@kp.org Brad Anderson, MD bradley.m.anderson@kp.org 503 249-3434

A Confusing Nomenclature Substance abuse Addiction Dependence Psychological dependence Chemical dependency Drug abuse

Opioid Dependence Physical dependence - a physiological state of adaptation to opioids Withdrawal syndrome with abstinence Relief of withdrawal with reintroduction As little as two weeks at therapeutic doses

Opioid Dependence Psychological dependence - subjective sense of need for opioids Positive effects Avoidance of negative effects associated with abstinence

Opioid Dependence Physical dependence does not equal psychological dependence. Physical dependence usually accompanies psychological dependence.

Addiction A primary, chronic disease with - genetic, - psychosocial and - environmental factors influencing its development and manifestations. It is often progressive, fatal and characterized by - impaired control, - preoccupation with use and - continued use despite adverse consequences. These symptoms may be continuous or periodic.

Addiction Latin for given over or awarded to, from ad - to + dicere - say, pronounce U2 - lifeless lifeline, running to stand still C.S. Lewis - an ever increasing craving for an ever diminishing pleasure.

Pain & Addiction Pain is often poorly treated in patients with addiction Fear of addicting patient Poor pain management skills Unfamiliarity with addiction Fear of regulatory sanctions

Pain & Addiction Patient concerns Fear of inadequately treated pain Fear of withdrawal Fear of relapse

Chronic Pain & Addiction Addiction - functioning decreases with increasing dose Pseudoaddiction - functioning increases with increasing dose

Common Recommendations Develop opiate therapy plan ( contract ) Use long acting / sustained release opiates Random urine toxicology Maximize non-opiate pharmacology Maximize non-pharmacologic modalities Pain clinic referral

Summary Pain & Addiction Demonstrate interest is in pain control, not medication (chronic pain treatment equation) Do everything through the front door Goal is pain control and increased functioning

Chronic Pain Treatment Equation chronic pain Tx = + other meds + physical therapy + relaxation opiates + ice/heat + education + etc

Chronic Pain & Addiction Treatment Goals Decrease pain Decrease associated symptoms anxiety depression insomnia Increase functioning Opioid remains a medication, not a drug of choice

Chronic Pain & Addiction To achieve these goals Addiction must be treated Use non-pharmacological modalities Use non-opioid medications If opioids are needed, use long acting or time released and take on scheduled basis Random urine toxicology

Chronic Pain & Addiction Opiate Therapy Plan Basic or Complex based upon addiction risk prescriber medication & dose amount & refill schedule patient s goals for therapy description of risks & responsibilities for patient signed by patient and prescriber

The 3 C s of Addiction Loss of CONTROL using month s meds in a few days or weeks early refills requests, obtaining meds from family, friends, Internet, street Adverse CONSEQUENCES sedation, OD, decrease functioning Preoccupation or COMPULSION reliance on opioids, poor compliance with other treatment modalities

Diagnosing Addiction Ask yourself Has this patient developed a relationship with this medication beyond what I prescribed it for? Does this patient go to lengths to get this medication that most of my patients don t?

Diagnosing Addiction Using supply before refills due Calling after hours, weekends, Friday at 5:00 Calling when PCP not available Multiple ER and UCC visits Calling provider at home Lost and/or stolen prescriptions Meds eaten by dog, fell in toilet, left in Seaside, picked up by ex-wife, etc...

Diagnosing Addiction Patient says med gives me energy Euphoria or sense of well-being Forging or changing scripts Borrowing or lending medications Obtaining meds from Internet or illegally Stockpiling medications Family/friends concerned about use Reported allergies to other analgesics

Diagnosing Addiction History of addictive disease Prior attempts to decrease or stop meds Annoyance at other s comments about use Guilt or embarrassment about use Use to treat non-targeted symptoms Use when no symptoms present Unsanctioned dosage increases